Search
for
Sort by
Research 751–780 of 1000+
- 원저 : 안드로겐성 탈모증의 임상적 고찰
- [Dermatologic therapy unit anti-androgens].
- NEW YORK ACADEMY OF MEDICINE, SECTION OF DERMATOLOGY AND SYPHILOLOGY
- Sexual Hormones in Human Skin
- The 5α-Recluctase System and Its Inhibitors
- From Axioms to New Insights into Dandruff
- Dienogest
- Tinea capitis in Benghazi, Libya
- The effect of the antiandrogen IIα-hydroxyprogesterone on sebum production and cholesterol concentration of sebum
- Pharmacological basis for clinical use of antiandrogens
- Die kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpräparat
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
- Anti-androgen therapy in dermatology: a review
- [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
- Finasteride
- Acne and Systemic Diseases
- PCOD-Management of ACNE
- Study of cutaneous manifestations in patients with polycystic ovarian syndrome attending a tertiary care centre
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- [Systematic treatment with sex hormones in dermatology].
- Three orphans one should know: red scalp, red ear and red scrotum syndrome
- Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
- Non‐thymoma‐associated exfoliative dermatitis in a European shorthair cat: A case report
- Lactiplantibacillus plantarum lysate isolated from green tea leaves alleviates the effects of Malassezia restricta on primary human scalp cells
- Color dilution alopecia in a Yorkshire
- QUESTIONS AND ANSWERS
- 50-Year-Old Female with a Burning Scalp and Hair Loss
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial